A Study in Healthy Men to Test How Well Different Doses of BI 1839100 Are Tolerated (1490-0003)
Clinical trial NCT05934955 · COMPLETED
Trial details
- NCT number
- NCT05934955
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-13
- Primary completion
- 2023-09-25
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.